Immune Pharmaceuticals, Inc. IMNP

Full chart Compare
Set alert

Price alert · IMNP

All alert types
0.00 0.00 (-39.62%)
0.0023 Day range 0.0051

52-week range unavailable

Ownership

Held by insiders 2.69%
Held by institutions 1.81%
Float held by institutions 1.86%
Institutions 11

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
CVI Holdings, LLC0.69%251,02947.70KJun 29, 2018
Barclays PLC0.52%187,05935.54KJun 29, 2018
Renaissance Technologies, LLC0.38%138,20526.26KJun 29, 2018
Vanguard Group, Inc. (The)0.38%136,84126.00KJun 29, 2018
Edmond De Rothschild Holding S.A.0.24%88,57516.83KJun 29, 2018
Credit Suisse Ag/0.11%38,3997.29KJun 29, 2018

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund0.76%275,667154.37KDec 30, 2017
Vanguard Extended Market Index Fund0.38%136,24176.29KDec 30, 2017
Fidelity Extended Market Index Fund0.04%15,2142.89KJun 29, 2018
Fidelity Total Market Index Fund0.02%7,1411.36KJun 29, 2018
Vanguard Balanced Index Fund0.01%3,0101.69KDec 30, 2017
IMNP insiders
InsiderRelationLatest transactionDateShares held
KAZADO DANIELDirectorConversion of Exercise of derivative securityJul 14, 201523,048
SIDRANSKY DAVIDDirectorStock Award(Grant)Jan 7, 201521,699
TEPER DANIEL GEDEONChief Executive OfficerConversion of Exercise of derivative securityOct 5, 20165,865,280